Authors
Loading...
Novel machine learning identifies distinct antibody signatures in kidney transplant rejection, suggesting new risk stratification tools.
Chakraborty et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: